2018-08-012024-05-17https://scholars.lib.ntu.edu.tw/handle/123456789/685607A Double Blind Randomized Placebo Controlled Clinical Trial for the Add-On Treatment of Schizophrenia Using a Selected Nmda Receptor Modulator